Engineered mucoperiosteal scaffold for cleft palate regeneration towards the non-immunogenic transplantation

• Published in: Scientific reports Vol. 11; no. 1; p. 14570
• Main Authors: Rizzo, M. I., Tomao, L., Tedesco, S., Cajozzo, M., Esposito, M., De Stefanis, C., Ferranti, A. M., Mezzogori, D., Palmieri, A., Pozzato, G., Algeri, M., Locatelli, F., Leone, L., Zama, M.
• Format: Journal Article
• Language: English
• Published: London Nature Publishing Group UK 16-07-2021; Nature Publishing Group; Nature Portfolio
• Subjects: 631/532; 639/166; 692/308; Birth defects; Bone growth; Bone marrow; Cleft lip/palate; Collagen; Congenital defects; Engraftment; Humanities and Social Sciences; Immunogenicity; Mesenchyme; Microenvironments; multidisciplinary; Osteogenesis; Regenerative medicine; Science; Science (multidisciplinary); Stem cell transplantation; Stem cells; Tissue engineering
• ISSN: 2045-2322; 2045-2322
• DOI: 10.1038/s41598-021-93951-w

Cleft lip and palate (CL/P) is the most prevalent craniofacial birth defect in humans. None of the surgical procedures currently used for CL/P repair lead to definitive correction of hard palate bone interruption. Advances in tissue engineering and regenerative medicine aim to develop new strategies to restore palatal bone interruption by using tissue or organ-decellularized bioscaffolds seeded with host cells. Aim of this study was to set up a new natural scaffold deriving from a decellularized porcine mucoperiosteum, engineered by an innovative micro-perforation procedure based on Quantum Molecular Resonance (QMR) and then subjected to in vitro recellularization with human bone marrow-derived mesenchymal stem cells (hBM-MSCs). Our results demonstrated the efficiency of decellularization treatment gaining a natural, non-immunogenic scaffold with preserved collagen microenvironment that displays a favorable support to hMSC engraftment, spreading and differentiation. Ultrastructural analysis showed that the micro-perforation procedure preserved the collagen mesh, increasing the osteoinductive potential for mesenchymal precursor cells. In conclusion, we developed a novel tissue engineering protocol to obtain a non-immunogenic mucoperiosteal scaffold suitable for allogenic transplantation and CL/P repair. The innovative micro-perforation procedure improving hMSC osteogenic differentiation potentially impacts for enhanced palatal bone regeneration leading to future clinical applications in humans.